Strengthening the Pharmaceutical Business Platform through the Transfer of JT's Pharmaceutical Business, the Acquisition of Akros, and Making Torii Pharmaceutical a Wholly Owned Subsidiary

A series of transactions to acquire Japan Tobacco's pharmaceutical business through an absorption-type company split, acquire shares in Akros, and make Torii Pharmaceutical a wholly owned subsidiary, thereby incorporating the pharmaceutical business platform. The central theme is the acquisition and restructuring of the pharmaceutical business through multiple transactions.